CELL AND GENE THERAPY INSIGHTS

April 2026 Issue

Volume 12 Issue 3

Cell and Gene Therapy Insights Volume 12 Issue 3
Download PDF

Featuring

Issue Spotlight: Induced pluripotent stem cells (iPSCs)
Translational Research & Clinical Development focus: Gene therapy R&D & translation
Other articles
Webinars

SPOTLIGHT

Induced pluripotent stem cells (iPSCs)

Expert Insight

Industrializing allogeneic iPSC-derived cell therapies: challenges and solutions

Industrializing allogeneic iPSC-derived cell therapies: challenges and solutions

Mathias Kroll, Kilian Kelly
28 April
Read

Viewpoint

Induced pluripotent stem cells and the rise of human-relevant in vitro models: promise, pitfalls, and the path forward

Induced pluripotent stem cells and the rise of human-relevant in vitro models: promise, pitfalls, and the path forward

Sonia Albini
2 March
Read

Interview

Off‑the‑shelf and on‑target: how iPSC‑derived CAR‑T cells could democratize autoimmune cell therapy

Off‑the‑shelf and on‑target: how iPSC‑derived CAR‑T cells could democratize autoimmune cell therapy

John Goulding
14 April
Read

Translational Research & Clinical Development FOCUS

Gene therapy R&D & translation

Viewpoint

Gene therapy 2.0: genetic therapies for non-genetic disorders in neurology

Gene therapy 2.0: genetic therapies for non-genetic disorders in neurology

Stephanie Schorge
29 April
Read

articles

Innovator Insight

Safety assays for quality control of ATMPs: addressing mycoplasma detection challenges

Safety assays for quality control of ATMPs: addressing mycoplasma detection challenges

Jens Björkman, Andreas Hecker
29 April
Read

Webinars